ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0320

Longitudinal Trends of Mineral and Bone Disorder Markers According to Diabetes Status and Glycemic Control in Patients on Peritoneal Dialysis: From PDOPPS, Korea

Session Information

Category: Bone and Mineral Metabolism

  • 502 Bone and Mineral Metabolism: Clinical

Authors

  • Seok, Suhyeon, Pusan National University Hospital, Busan, Korea (the Republic of)
  • Jeon, Ji Hyun, Pusan National University Hospital, Busan, Korea (the Republic of)
  • Kim, Da Woon, Pusan National University Hospital, Busan, Korea (the Republic of)
  • Seong, Eun Young, Pusan National University Hospital, Busan, Korea (the Republic of)
  • Song, Sang Heon, Pusan National University Hospital, Busan, Korea (the Republic of)
Background

This study evaluates the influence of diabetes mellitus (DM) and glycemic control on longitudinal chronic kidney disease-mineral and bone disorder (CKD-MBD) trajectories and fracture risk in peritoneal dialysis (PD) patients, who are continuously exposed to glucose through dialysate.

Methods

We analyzed 766 PD patients (407 non-DM, 359 DM) from the Korea PDOPPS cohort (2019–2021). Linear Mixed Models (LMM) were utilized to evaluate the longitudinal trajectories of MBD markers according to DM status and glycemic control (stratified by HbA1c 8.0%). Cox proportional hazards models were employed to assess fracture risk.

Results

Baseline parathyroid hormone (PTH) (247.0 vs. 311.0 pg/mL) and albumin (3.54 vs. 3.73 g/dL) were lower in the DM group (p<0.001). LMM confirmed DM patients maintained lower PTH and albumin trajectories throughout follow-up (p<0.001). Within the DM group, poor glycemic control (HbA1c ≥8.0%) was associated with lower baseline phosphate (5.07 vs. 5.26 mg/dL, p=0.005) but showed a steeper longitudinal increase (p-interaction=0.040). Regarding fractures, the DM group exhibited a higher hazard ratio (Adjusted hazard ratio 1.647, 95% CI 0.587–4.621) without statistical significance (p=0.343).

Conclusion

DM and hyperglycemia significantly alter CKD-MBD trajectories in PD. Longitudinal phosphate monitoring is essential to avoid misinterpreting mineral status in poorly controlled patients.

Acknowledgment

Data were sourced from PDOPPS, Korea

figure 1

figure 2